All In Biotech

Drug Trial Radar · NCT07594119

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 312 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

312

Planned (sponsor's estimate)

Start

Sep 1, 2026

Primary completion

Jul 2029

Study completion Sep 2029

Sponsor

Lead sponsor
Rapport Therapeutics Inc.Industry
Sponsor type
Industry
First posted
May 18, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.

Conditions

  • Focal Seizure
  • Epilepsy
  • Focal Epilepsy

Interventions

  • RAP-219Drug

    RAP-219 medium dose tablets administered orally daily

  • RAP-219Drug

    RAP-219 low dose tablets administered orally daily

  • PlaceboOther

    Matching placebo tablets administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Median Percent Change in Seizure FrequencyTime frame: End of double-blind treatment period (end of week 14) vs Baseline

Locations

14 sites in 3 countries. Site status is shown where the registry gives one.

  • Clinical Study Center

    Huntsville, Alabama · Recruiting

  • Clinical Study Center

    Bentonville, Arkansas · Recruiting

  • Clinical Study Center

    Colorado Springs, Colorado · Recruiting

  • Clinical Study Center

    Maitland, Florida · Recruiting

  • Clinical Study Center

    Miami, Florida · Recruiting

  • Clinical Study Center

    Honolulu, Hawaii · Recruiting

  • Clinical Study Center

    Chicago, Illinois · Recruiting

  • Clinical Study Center

    Omaha, Nebraska · Recruiting

  • Clinical Study Center

    New York, New York · Recruiting

  • Clinical Study Center

    Raleigh, North Carolina · Recruiting

  • Clinical Study Center

    Nashville, Tennessee · Recruiting

  • Clinical Study Center

    Houston, Texas · Recruiting

  • Clinical Study Center

    Melbourne, Australia · Recruiting

  • Clinical Study Center

    Seoul, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.